Date/time: April 21, 2021 at 09:30 AM – 10:45 AM PST (6.30 am in HI)

• Speakers: Dr Tipu Khan, MD, and Jeanne M. Gripshover, APRN (live virtual webinar and interactive Q&A)

• Registration Link

The session will focus on simplification of HCV management and how to apply it during the COVID-19 pandemic.

After participating in this program, you will be able to:

• Understand the impact of COVID-19 on HCV screening, diagnosis, and HCV elimination progress

• Examine the effect of simplified pre-treatment, on-treatment and post-treatment protocols allowing decentralization of HCV management for the majority of patients

• Identify current barriers to HCV care in the COVID-19 era

• Recognize the role of technology and telemedicine for HCV care in the COVID-19 era